Akari Therapeutics, Plc Gains 25.43%

Fri 10 Jan 20 at 05:30 PM
Akari Therapeutics, Plc Gains 25.43%

Akari Therapeutics, Plc (AKTX:NASDAQ) shot up at $2.17, representing a gain of 25.4%. On Thu 09 Jan 20, AKTX:NASDAQ touched a New 2-Week Intraday High of $1.79. The stock got featured on our News Catalysts scanner on Fri 10 Jan 20 at 10:01 AM in the 'BIOTECH' category. From Wed 18 Dec 19, the stock recorded 35.71% Up Days and 46.67% Green Days

The stock spiked on Mon 02 Dec 19 at $2.64 with a volume of 7M+, and its share price has been moving sideways in recent weeks.

About Akari Therapeutics, Plc (AKTX:NASDAQ)

Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.

Share